Medical cannabis in France: 14 associations demand urgent implementation
The debate on medical cannabis in France has been reignited. Fourteen patient and healthcare professional associations have recently joined forces to demand the concrete application of the law. Despite promises from the authorities, access to cannabis-based treatments remains very limited for people suffering from serious illnesses.
For several years, France has been conducting a national experiment to evaluate the efficacy of therapeutic cannabis. Although preliminary results are considered positive by doctors, the definitive legal framework is slow to be established. The associations denounce administrative sluggishness that directly penalizes patients in chronic pain.
The main sticking point concerns the reimbursement of medications and the securing of the French production sector. Currently, many patients must turn to expensive solutions or unofficial channels to relieve their pain. The signatories of the appeal emphasize that France is lagging behind its European neighbors, where medical use is already widely regulated.
Faced with this situation, the associations are asking the government to quickly clarify the legal status of these treatments. They are calling for generalized access to medication for eligible patients, as well as financial support to guarantee high-quality local production.
The Ministry of Health has not yet announced any new concrete measures following this mobilization. The issue therefore remains at the heart of political discussions, as thousands of patients await a lasting solution to improve their daily quality of life.